Organon (OGN) Free Cash Flow (2020 - 2026)

Organon (OGN) posted quarterly Free Cash Flow of $188.0 million for Q1 2026, up 337.21% year-over-year from $43.0 million in Q1 2025, and up 95.83% on a QoQ basis from $96.0 million in Q4 2025.

Organon (OGN) Free Cash Flow (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Free Cash Flow for 7 consecutive years, with $188.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Free Cash Flow rose 337.21% year-over-year to $188.0 million; the TTM figure through Mar 2026 stood at $683.0 million (down 12.1% YoY), while the FY2025 annual figure was $538.0 million, down 29.58% from the prior year.
  • Free Cash Flow came in at $188.0 million for Q1 2026 at Organon, up from $96.0 million in the prior quarter.
  • The five-year high for Free Cash Flow was $335.0 million in Q4 2024, with the low at -$44.0 million in Q2 2023.
  • Average Free Cash Flow over 5 years is $158.8 million, with a median of $181.0 million recorded in 2025.
  • Across the five-year window, Free Cash Flow surged 1800.0% in 2022 and tumbled 141.51% in 2023, its largest moves.
  • Year by year, Free Cash Flow stood at $204.0 million in 2022, then soared by 55.88% to $318.0 million in 2023, then grew by 5.35% to $335.0 million in 2024, then sank by 71.34% to $96.0 million in 2025, then surged by 95.83% to $188.0 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $188.0 million, $96.0 million, and $218.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.01 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.47 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.56 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 547.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.93 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.48 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.43 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.18 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 346.00 Mn
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 188.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 188.00 Mn
Mar 31, 2026 188.00 Mn
Dec 31, 2025 96.00 Mn
Dec 31, 2025 96.00 Mn
Sep 30, 2025 218.00 Mn
Sep 30, 2025 218.00 Mn
Jun 30, 2025 181.00 Mn
Jun 30, 2025 181.00 Mn
Mar 31, 2025 43.00 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 335.00 Mn
Dec 31, 2024 335.00 Mn
Sep 30, 2024 99.00 Mn
Sep 30, 2024 99.00 Mn
Jun 30, 2024 300.00 Mn
Jun 30, 2024 300.00 Mn
Mar 31, 2024 30.00 Mn
Mar 31, 2024 30.00 Mn
Dec 31, 2023 318.00 Mn
Dec 31, 2023 318.00 Mn